Drug company stands to benefit from legislation
A drug company stands to financially benefit from proposed state legislation that could invalidate a class-action invasion-of-privacy lawsuit against it.
Canada's pharmaceutical intellectual property laws need major reform to encourage and protect innovation in developing new drugs, states an analysis in CMAJ.